About us

Innovative Approach

Our revolutionary approach combines early diagnosis and a new treatment concept. This will prevent current and future generations from suffering from Alzheimer’s.

The Immungenetics drug challenge leverages a causative disease mechanism to diagnose pre-clinical AD.

Our drug improves Aβ monomer clearance and restores the autophagic flux, a mechanism essential for the removal of Aβ and Tau aggregates.

To learn more, please contact us.

About us

Innovative Approach

Our revolutionary approach combines early diagnosis and a new treatment concept. This will prevent current and future generations from suffering from Alzheimer’s.

The Immungenetics drug challenge leverages a causative disease mechanism to diagnose pre-clinical AD.

Our drug improves Aβ monomer clearance and restores the autophagic flux, a mechanism essential for the removal of Aβ and Tau aggregates.

To learn more, please contact us.

Clinical
Development

Do you want to know more?

Please use our contact form. We will get back to you as soon as possible with further details.
Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
=